Revisão histórica da síndrome de Lynch

Translated title of the contribution: Historical review of Lynch syndrome

Andrew I. Wolf, Adam H. Buchanan, Linda Farkas

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Lynch syndrome was formerly known as Hereditary Nonpolyposis Colorectal Cancer. Currently, these two nomenclatures each have their unique definitions and are no longer used interchangeably. The history of hereditary nonpolyposis colorectal cancer was first recognized formally in the literature by Henry Lynch in 1967. With advances of molecular genetics, there has been a transformation from clinical phenotype to genotype diagnostics. This has led to the ability to diagnose affected patients before they manifest with cancer, and therefore allow preventative surveillance strategies. Genotype diagnostics has shown a difference in penetrance of different cancer risks dependent on the gene containing the mutation. Surgery is recommended as prevention for some cancers; for others they are reserved for once cancer is noted. Various surveillance strategies are recommended dependent on the relative risk of cancer and the ability to intervene with surgery to impact on survival. Risk reduction through aspirin has shown some recent promise, and continues to be studied.

Original languagePortuguese
Pages (from-to)95-110
Number of pages16
JournalJournal of Coloproctology
Volume33
Issue number2
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Hereditary Nonpolyposis Colorectal Neoplasms
Aptitude
Neoplasms
Genotype
Penetrance
Risk Reduction Behavior
Aspirin
Molecular Biology
History
Phenotype
Mutation
Survival
Genes

Keywords

  • Amsterdam criteria
  • Bethesda criteria
  • Colorectal cancer
  • Familial cancer
  • Family X
  • Hereditary nonpolyposis colorectal cancer
  • Immunohistochemistry: IHC
  • Lynch syndrome
  • Microsatellite instability: MSI
  • Mismatch repair
  • Muir-Torre syndrome
  • Turcot syndrome

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Revisão histórica da síndrome de Lynch. / Wolf, Andrew I.; Buchanan, Adam H.; Farkas, Linda.

In: Journal of Coloproctology, Vol. 33, No. 2, 01.01.2013, p. 95-110.

Research output: Contribution to journalReview article

Wolf, Andrew I. ; Buchanan, Adam H. ; Farkas, Linda. / Revisão histórica da síndrome de Lynch. In: Journal of Coloproctology. 2013 ; Vol. 33, No. 2. pp. 95-110.
@article{75e98601afee45dbb275acfd8190fb08,
title = "Revis{\~a}o hist{\'o}rica da s{\'i}ndrome de Lynch",
abstract = "Lynch syndrome was formerly known as Hereditary Nonpolyposis Colorectal Cancer. Currently, these two nomenclatures each have their unique definitions and are no longer used interchangeably. The history of hereditary nonpolyposis colorectal cancer was first recognized formally in the literature by Henry Lynch in 1967. With advances of molecular genetics, there has been a transformation from clinical phenotype to genotype diagnostics. This has led to the ability to diagnose affected patients before they manifest with cancer, and therefore allow preventative surveillance strategies. Genotype diagnostics has shown a difference in penetrance of different cancer risks dependent on the gene containing the mutation. Surgery is recommended as prevention for some cancers; for others they are reserved for once cancer is noted. Various surveillance strategies are recommended dependent on the relative risk of cancer and the ability to intervene with surgery to impact on survival. Risk reduction through aspirin has shown some recent promise, and continues to be studied.",
keywords = "Amsterdam criteria, Bethesda criteria, Colorectal cancer, Familial cancer, Family X, Hereditary nonpolyposis colorectal cancer, Immunohistochemistry: IHC, Lynch syndrome, Microsatellite instability: MSI, Mismatch repair, Muir-Torre syndrome, Turcot syndrome",
author = "Wolf, {Andrew I.} and Buchanan, {Adam H.} and Linda Farkas",
year = "2013",
month = "1",
day = "1",
doi = "10.1590/S2237-93632013000200010",
language = "Portuguese",
volume = "33",
pages = "95--110",
journal = "Journal of Coloproctology",
issn = "2237-9363",
publisher = "Sociedade Brasileira de Coloproctologia",
number = "2",

}

TY - JOUR

T1 - Revisão histórica da síndrome de Lynch

AU - Wolf, Andrew I.

AU - Buchanan, Adam H.

AU - Farkas, Linda

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Lynch syndrome was formerly known as Hereditary Nonpolyposis Colorectal Cancer. Currently, these two nomenclatures each have their unique definitions and are no longer used interchangeably. The history of hereditary nonpolyposis colorectal cancer was first recognized formally in the literature by Henry Lynch in 1967. With advances of molecular genetics, there has been a transformation from clinical phenotype to genotype diagnostics. This has led to the ability to diagnose affected patients before they manifest with cancer, and therefore allow preventative surveillance strategies. Genotype diagnostics has shown a difference in penetrance of different cancer risks dependent on the gene containing the mutation. Surgery is recommended as prevention for some cancers; for others they are reserved for once cancer is noted. Various surveillance strategies are recommended dependent on the relative risk of cancer and the ability to intervene with surgery to impact on survival. Risk reduction through aspirin has shown some recent promise, and continues to be studied.

AB - Lynch syndrome was formerly known as Hereditary Nonpolyposis Colorectal Cancer. Currently, these two nomenclatures each have their unique definitions and are no longer used interchangeably. The history of hereditary nonpolyposis colorectal cancer was first recognized formally in the literature by Henry Lynch in 1967. With advances of molecular genetics, there has been a transformation from clinical phenotype to genotype diagnostics. This has led to the ability to diagnose affected patients before they manifest with cancer, and therefore allow preventative surveillance strategies. Genotype diagnostics has shown a difference in penetrance of different cancer risks dependent on the gene containing the mutation. Surgery is recommended as prevention for some cancers; for others they are reserved for once cancer is noted. Various surveillance strategies are recommended dependent on the relative risk of cancer and the ability to intervene with surgery to impact on survival. Risk reduction through aspirin has shown some recent promise, and continues to be studied.

KW - Amsterdam criteria

KW - Bethesda criteria

KW - Colorectal cancer

KW - Familial cancer

KW - Family X

KW - Hereditary nonpolyposis colorectal cancer

KW - Immunohistochemistry: IHC

KW - Lynch syndrome

KW - Microsatellite instability: MSI

KW - Mismatch repair

KW - Muir-Torre syndrome

KW - Turcot syndrome

UR - http://www.scopus.com/inward/record.url?scp=84882623014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882623014&partnerID=8YFLogxK

U2 - 10.1590/S2237-93632013000200010

DO - 10.1590/S2237-93632013000200010

M3 - Review article

VL - 33

SP - 95

EP - 110

JO - Journal of Coloproctology

JF - Journal of Coloproctology

SN - 2237-9363

IS - 2

ER -